convallatoxin and Coronary-Disease

convallatoxin has been researched along with Coronary-Disease* in 2 studies

Trials

1 trial(s) available for convallatoxin and Coronary-Disease

ArticleYear
[Chronopharmacodynamics of delayed-action cardiac glycosides and nitrates].
    Kardiologiia, 1990, Volume: 30, Issue:12

    In 96 patients with coronary heart disease and stage II circulatory failure, the chronopharmacodynamics of strophanthin, corglycon, and nitrosorbide was studied by using acute clinical and pharmacological tests in the morning (8.00 a.m.), in the afternoon (2.00 p.m.), and in the evening (8.00 p.m.). Central and peripheral hemodynamic parameters were measured prior to and following 5, 15, 30, 60, and 120 min of intravenous injection of cardiac glycosides or sublingual administration of nitrosorbide in a dose of 10 mg for 240 min. The investigations showed that there were the most profound hemodynamic changes in the morning if strophanthin was used and in the afternoon if corglycon was given. The maximal reduction in heart pre- and afterload was seen in the morning when nitrosorbide was applied, the most improvement in central hemodynamic parameters was observed in the evening when nitrosorbide was used.

    Topics: Aged; Cardiomyopathy, Dilated; Circadian Rhythm; Coronary Disease; Delayed-Action Preparations; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged; Strophanthins

1990

Other Studies

1 other study(ies) available for convallatoxin and Coronary-Disease

ArticleYear
[INTRAMUSCULAR ADMINISTRATION OF STROPHANTHIN AND CORGLYCON IN CIRCULATORY INSUFFICIENCY IN PATIENTS WITH CORONARY DISORDERS].
    Sovetskaia meditsina, 1963, Volume: 26

    Topics: Cardiac Glycosides; Coronary Disease; Humans; Injections, Intramuscular; Strophanthins

1963